Chemomab Therapeutics (CMMB) Shares Outstanding (2020 - 2026)
Chemomab Therapeutics (CMMB) recorded Shares Outstanding of 6.38 million in Q2 2026, up 42.1% from 4.49 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Shares Outstanding (2020 - 2026) Analysis & Trends
Starting with Q4 2020, Chemomab Therapeutics' Shares Outstanding history includes 23 quarters.
- Annual Shares Outstanding has increased for five straight years, with a five-year compound annual growth rate of 30.1% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding came in at 4.49 million in FY2024 (+52.8%), 2.94 million in FY2023 (+3.3%), 2.84 million in FY2022 (+9.7%) and 2.59 million in FY2021 (+51.7%).
- On a year-over-year basis, Shares Outstanding has increased for 11 consecutive quarters, with growth averaging 43.0% over the last eight quarters.
- Peak year-over-year performance for Shares Outstanding in the last five years was growth of 52.8% in Q3 2025, against a decline of 3.4% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 6.38 million (Q1 2026), 6.38 million (Q4 2025) and 4.49 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 892.40 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 1.94 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.55 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 540.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Chemomab Therapeutics | 6.82 Mn | -28.33 Mn | - | 6.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.38 Mn |
| Mar 31, 2026 | 6.38 Mn |
| Dec 31, 2025 | 6.38 Mn |
| Sep 30, 2025 | 4.49 Mn |
| Jun 30, 2025 | 4.49 Mn |
| Mar 31, 2025 | 4.49 Mn |
| Dec 31, 2024 | 4.49 Mn |
| Sep 30, 2024 | 2.94 Mn |
| Jun 30, 2024 | 2.94 Mn |
| Mar 31, 2024 | 2.94 Mn |
| Dec 31, 2023 | 2.94 Mn |
| Sep 30, 2023 | 2.76 Mn |
| Jun 30, 2023 | 2.76 Mn |
| Mar 31, 2023 | 2.76 Mn |
| Dec 31, 2022 | 2.84 Mn |
| Sep 30, 2022 | 2.86 Mn |
| Jun 30, 2022 | 2.85 Mn |
| Mar 31, 2022 | 2.85 Mn |
| Dec 31, 2021 | 2.59 Mn |
| Sep 30, 2021 | 2.85 Mn |
API Access
Chemomab Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();